MicroRNA-mediated non-viral direct conversion of embryonic fibroblasts to cardiomyocytes: comparison of commercial and synthetic non-viral vectors

Hyosuk Kim, Dongkyu Kim, Sook Hee Ku, Kwang Meyung Kim, Sun Hwa Kim, Ick Chan Kwon

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Technological advances opened up new ways of directing cell fate conversion from one cell lineage to another. The direct cell conversion technique has recently attracted much attention in regenerative medicine to treat devastated organs and tissues, particularly having limited regenerative capacity such as the heart and brain. Unfortunately, its clinical application is severely limited due to a safety concern and immunogenicity of viral vectors, as human gene therapy did in the beginning stages. In this study, we examined the possibility of adopting non-viral vectors to direct cell conversion from mouse embryonic fibroblasts to induced cardiomyocytes (iCM) by transient transfection of four types of chemically synthesized micro-RNA mimics (miRNA-1, 133, 208, and 499). Herein, we tested several commercial and synthetic non-viral gene delivery carriers, which could be divided into three different categories: polymers [branched PEI (bPEI), bioreducible PEI (PEI-SS), deoxycholic acid-conjugated PEI (DA-PEI), jetPEI™, SuperFect™], lipids (Lipofectamine 2000™), and peptides (PepMute™). According to the analyses of physicochemical properties, cellular uptake, and cytotoxicity of the carrier/miRNA complexes, DA-PEI exhibited excellent miRNA delivery efficiency to mouse embryonic fibroblasts. One week after a single treatment of DA-PEI/miRNA without other adjuvants, the cells started to express cardiomyocyte-specific markers, such as α-actinin and α-MHC, indicating the formation of cardiomyocyte-like cells. Although the overall frequency of non-viral vector induced cardiomyogenic transdifferentiation was quite low (ca. 0.2%), this study can provide compelling support to develop clinically applicable transdifferentiation techniques.

Original languageEnglish
Pages (from-to)1-16
Number of pages16
JournalJournal of Biomaterials Science, Polymer Edition
DOIs
Publication statusAccepted/In press - 2017 Feb 15

Fingerprint

Polyetherimides
Fibroblasts
MicroRNAs
Cardiac Myocytes
Deoxycholic Acid
Acids
Actinin
Regenerative Medicine
Gene therapy
Cell Lineage
Genetic Therapy
Transfection
Cytotoxicity
RNA
Polymers
Lipids
Peptides
Brain
Safety
Genes

Keywords

  • cardiomyocyte
  • miRNA
  • Non-viral delivery
  • polyethylenimine
  • transdifferentiation

ASJC Scopus subject areas

  • Bioengineering
  • Biophysics
  • Biomaterials
  • Biomedical Engineering

Cite this

MicroRNA-mediated non-viral direct conversion of embryonic fibroblasts to cardiomyocytes : comparison of commercial and synthetic non-viral vectors. / Kim, Hyosuk; Kim, Dongkyu; Ku, Sook Hee; Kim, Kwang Meyung; Kim, Sun Hwa; Kwon, Ick Chan.

In: Journal of Biomaterials Science, Polymer Edition, 15.02.2017, p. 1-16.

Research output: Contribution to journalArticle

@article{1b2be8485ea64d9f83d4e8662cee42cf,
title = "MicroRNA-mediated non-viral direct conversion of embryonic fibroblasts to cardiomyocytes: comparison of commercial and synthetic non-viral vectors",
abstract = "Technological advances opened up new ways of directing cell fate conversion from one cell lineage to another. The direct cell conversion technique has recently attracted much attention in regenerative medicine to treat devastated organs and tissues, particularly having limited regenerative capacity such as the heart and brain. Unfortunately, its clinical application is severely limited due to a safety concern and immunogenicity of viral vectors, as human gene therapy did in the beginning stages. In this study, we examined the possibility of adopting non-viral vectors to direct cell conversion from mouse embryonic fibroblasts to induced cardiomyocytes (iCM) by transient transfection of four types of chemically synthesized micro-RNA mimics (miRNA-1, 133, 208, and 499). Herein, we tested several commercial and synthetic non-viral gene delivery carriers, which could be divided into three different categories: polymers [branched PEI (bPEI), bioreducible PEI (PEI-SS), deoxycholic acid-conjugated PEI (DA-PEI), jetPEI™, SuperFect™], lipids (Lipofectamine 2000™), and peptides (PepMute™). According to the analyses of physicochemical properties, cellular uptake, and cytotoxicity of the carrier/miRNA complexes, DA-PEI exhibited excellent miRNA delivery efficiency to mouse embryonic fibroblasts. One week after a single treatment of DA-PEI/miRNA without other adjuvants, the cells started to express cardiomyocyte-specific markers, such as α-actinin and α-MHC, indicating the formation of cardiomyocyte-like cells. Although the overall frequency of non-viral vector induced cardiomyogenic transdifferentiation was quite low (ca. 0.2{\%}), this study can provide compelling support to develop clinically applicable transdifferentiation techniques.",
keywords = "cardiomyocyte, miRNA, Non-viral delivery, polyethylenimine, transdifferentiation",
author = "Hyosuk Kim and Dongkyu Kim and Ku, {Sook Hee} and Kim, {Kwang Meyung} and Kim, {Sun Hwa} and Kwon, {Ick Chan}",
year = "2017",
month = "2",
day = "15",
doi = "10.1080/09205063.2017.1287537",
language = "English",
pages = "1--16",
journal = "Journal of Biomaterials Science, Polymer Edition",
issn = "0920-5063",
publisher = "Taylor and Francis Ltd.",

}

TY - JOUR

T1 - MicroRNA-mediated non-viral direct conversion of embryonic fibroblasts to cardiomyocytes

T2 - comparison of commercial and synthetic non-viral vectors

AU - Kim, Hyosuk

AU - Kim, Dongkyu

AU - Ku, Sook Hee

AU - Kim, Kwang Meyung

AU - Kim, Sun Hwa

AU - Kwon, Ick Chan

PY - 2017/2/15

Y1 - 2017/2/15

N2 - Technological advances opened up new ways of directing cell fate conversion from one cell lineage to another. The direct cell conversion technique has recently attracted much attention in regenerative medicine to treat devastated organs and tissues, particularly having limited regenerative capacity such as the heart and brain. Unfortunately, its clinical application is severely limited due to a safety concern and immunogenicity of viral vectors, as human gene therapy did in the beginning stages. In this study, we examined the possibility of adopting non-viral vectors to direct cell conversion from mouse embryonic fibroblasts to induced cardiomyocytes (iCM) by transient transfection of four types of chemically synthesized micro-RNA mimics (miRNA-1, 133, 208, and 499). Herein, we tested several commercial and synthetic non-viral gene delivery carriers, which could be divided into three different categories: polymers [branched PEI (bPEI), bioreducible PEI (PEI-SS), deoxycholic acid-conjugated PEI (DA-PEI), jetPEI™, SuperFect™], lipids (Lipofectamine 2000™), and peptides (PepMute™). According to the analyses of physicochemical properties, cellular uptake, and cytotoxicity of the carrier/miRNA complexes, DA-PEI exhibited excellent miRNA delivery efficiency to mouse embryonic fibroblasts. One week after a single treatment of DA-PEI/miRNA without other adjuvants, the cells started to express cardiomyocyte-specific markers, such as α-actinin and α-MHC, indicating the formation of cardiomyocyte-like cells. Although the overall frequency of non-viral vector induced cardiomyogenic transdifferentiation was quite low (ca. 0.2%), this study can provide compelling support to develop clinically applicable transdifferentiation techniques.

AB - Technological advances opened up new ways of directing cell fate conversion from one cell lineage to another. The direct cell conversion technique has recently attracted much attention in regenerative medicine to treat devastated organs and tissues, particularly having limited regenerative capacity such as the heart and brain. Unfortunately, its clinical application is severely limited due to a safety concern and immunogenicity of viral vectors, as human gene therapy did in the beginning stages. In this study, we examined the possibility of adopting non-viral vectors to direct cell conversion from mouse embryonic fibroblasts to induced cardiomyocytes (iCM) by transient transfection of four types of chemically synthesized micro-RNA mimics (miRNA-1, 133, 208, and 499). Herein, we tested several commercial and synthetic non-viral gene delivery carriers, which could be divided into three different categories: polymers [branched PEI (bPEI), bioreducible PEI (PEI-SS), deoxycholic acid-conjugated PEI (DA-PEI), jetPEI™, SuperFect™], lipids (Lipofectamine 2000™), and peptides (PepMute™). According to the analyses of physicochemical properties, cellular uptake, and cytotoxicity of the carrier/miRNA complexes, DA-PEI exhibited excellent miRNA delivery efficiency to mouse embryonic fibroblasts. One week after a single treatment of DA-PEI/miRNA without other adjuvants, the cells started to express cardiomyocyte-specific markers, such as α-actinin and α-MHC, indicating the formation of cardiomyocyte-like cells. Although the overall frequency of non-viral vector induced cardiomyogenic transdifferentiation was quite low (ca. 0.2%), this study can provide compelling support to develop clinically applicable transdifferentiation techniques.

KW - cardiomyocyte

KW - miRNA

KW - Non-viral delivery

KW - polyethylenimine

KW - transdifferentiation

UR - http://www.scopus.com/inward/record.url?scp=85013030292&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85013030292&partnerID=8YFLogxK

U2 - 10.1080/09205063.2017.1287537

DO - 10.1080/09205063.2017.1287537

M3 - Article

C2 - 28277007

AN - SCOPUS:85013030292

SP - 1

EP - 16

JO - Journal of Biomaterials Science, Polymer Edition

JF - Journal of Biomaterials Science, Polymer Edition

SN - 0920-5063

ER -